-
DAPI Nuclear Stain Solution: Practical Protocol
2026-09-08
DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution, SKU K2402, provides a pre-diluted fluorescent DNA binding dye for nuclear visualization, cell viability assessment, and apoptosis-related nuclear evaluation. It is most appropriate for fixed or membrane-compromised samples analyzed by fluorescence microscopy or flow cytometry, rather than routine imaging of intact live cells.
-
OCT2/MATE1 Inhibition by Antiemetic Drugs
2026-09-08
George and colleagues evaluated how five 5-HT3 receptor antagonist drugs affect the renal organic-cation transporters OCT2 and MATE1. Their cell-based experiments identify marked compound-specific differences in transporter inhibition and show why antiemetic therapy can be relevant to serotonin receptor signaling research, renal drug disposition, and potential transporter-mediated interactions.
-
CPSIT_0844 Drives IL-6 and IL-8 via TLR2/4
2026-09-07
The reference study identifies the Chlamydia psittaci inclusion membrane protein CPSIT_0844 as a proinflammatory factor that induces IL-6 and IL-8 in human monocytes. Its perturbation experiments connect CPSIT_0844 to a TLR2/TLR4–MyD88 axis and downstream JNK, p38, and NF-κB signaling, providing a mechanistic framework for C. psittaci-associated inflammation.
-
Tβ4, Notch/NF-κB, and Limb Ischemia Angiogenesis
2026-09-07
The reference study links thymosin-β4 overexpression with enhanced endothelial viability, migration, and angiogenic behavior in vitro and improved vascular remodeling markers in a mouse model of critical limb ischemia. Its key contribution is the proposed connection between these effects and coordinated Notch/NF-κB pathway activity, while pharmacological inhibition experiments provide mechanistic support without establishing direct molecular binding.
-
PINK1/Park2 Mitophagy in Fatty Liver Disease
2026-09-05
The reference study links Park2-mediated mitophagy with reduced lipid-associated mitochondrial injury in an oleic-acid cellular model of non-alcoholic fatty liver disease. By combining Park2 overexpression and knockdown with imaging, biochemical, inflammatory, and molecular readouts, it provides a mechanistic basis for further investigation while remaining limited by its in vitro design.
-
Phebestin Reveals a New Antiplasmodial Strategy
2026-09-04
The reference study identifies phebestin, a bestatin-related aminopeptidase inhibitor, as a nanomolar inhibitor of Plasmodium falciparum growth with activity against both chloroquine-sensitive and chloroquine-resistant parasites. By combining phenotypic assays, stage-specific testing, molecular modeling, and mouse infection studies, the work supports parasite metalloaminopeptidases as tractable targets for antimalarial discovery while also defining important translational limitations.
-
EdU Imaging Kits (HF594): 5 Practical Scenarios
2026-09-04
This scenario-based guide explains how EdU Imaging Kits (HF594), SKU K2243, support DNA synthesis measurement in fluorescence microscopy and flow cytometry. It addresses assay design, compatibility, optimization, interpretation, and practical vendor-selection criteria without equating EdU incorporation with viability or completed cell division.
-
Verteporfin Activates IRE1α to Enhance AKT Inhibition
2026-09-03
A 2025 Cell Chemical Biology study identifies verteporfin as a molecular glue-like activator of IRE1α, promoting its dimerization through a mechanism involving His692. The resulting IRE1α–XBP1–miR-153 pathway links endoplasmic reticulum stress signaling to PTEN loss, AKT activation, and BACH1 suppression, while combined AKT inhibition strengthens antitumor activity in breast cancer models.
-
Fluo-4 AM Workflows for Calcium Imaging
2026-09-03
Build faster, cleaner live-cell calcium assays with Fluo-4 AM, a bright cell-permeant probe suited to kinetic signaling and pharmacology workflows. This guide connects practical dye optimization with emerging bioelectronic photoreceptor research while clearly separating validated evidence from forward-looking assay design.
-
Fluo-4 AM: Reliable Calcium Signaling Assays
2026-09-02
This scenario-based guide explains how Fluo-4 AM supports intracellular calcium concentration measurement, assay compatibility, protocol control, and interpretation in biomedical research. It also outlines practical vendor-selection criteria for SKU B8807, including formulation, storage, handling, and cost-efficiency considerations.
-
EdU Imaging Kits (Cy5): 5 Practical Scenarios
2026-09-02
This scenario-driven guide explains how EdU Imaging Kits (Cy5), SKU K1076, support reproducible S-phase DNA synthesis measurement in microscopy and flow cytometry. It connects assay design, optimization, interpretation, and vendor selection to common laboratory challenges while distinguishing proliferation data from direct viability measurements.
-
Fluo-4 AM for Calcium Signaling Assays
2026-09-01
Use Fluo-4 AM to convert rapid intracellular Ca2+ changes into actionable readouts for podocyte biology, receptor trafficking, and drug-response studies. This workflow connects live-cell calcium imaging with the GPR107–AT1R pathway implicated in diabetic nephropathy, while emphasizing controls, normalization, and troubleshooting for reproducible data.
-
Optimized GBA1 mRNA for Gaucher Disease Therapy
2026-09-01
The reference study systematically engineers human GBA1 mRNA through untranslated-region design, codon optimization, and poly(A)-tail modification to improve glucocerebrosidase expression and persistence. Its lead constructs restored lysosomal phenotypes in GBA1-knockout cells and produced detectable enzyme activity in mouse liver and spleen after lipid-nanoparticle delivery, supporting further evaluation of mRNA therapy for Gaucher disease.
-
DFO for Latent Fingerprint Detection Workflows
2026-08-31
DFO (9H-1,8-Diazafluoren-9-one) converts amino-acid residues in latent prints into a fluorescence-based detection opportunity, with particular value on paper and other porous evidence. This guide connects reagent handling, matrix-aware validation, imaging, and troubleshooting while clearly separating the forensic dye from the deferoxamine compound abbreviated DFO in wound-healing research.
-
AZD2461: A Practical PARP Assay Workflow
2026-08-31
Build a more informative AZD2461 workflow by separating growth inhibition from true cell killing, then pair PARP-1, cell-cycle, and viability readouts. Its low P-glycoprotein affinity makes the compound especially useful for breast cancer research focused on resistance biology and BRCA1-mutated tumor models.